Join to view full profile
Memorial Sloan Kettering Cancer Center New York1275 York AvenueNew York, NY 10021
Dr. Rimner is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2006 - 2010- Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2005 - 2006
Eberhard Karls University Faculty of MedicineClass of 2003
Certifications & Licensure
FL State Medical License 2023 - Present
NY State Medical License 2010 - 2026
NJ State Medical License 2022 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
Clinical Trials
- Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
- Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer
- Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer Start of enrollment: 2013 Jul 05
Publications & Presentations
PubMed
- European lung cancer congress 2026 - the thoracic radiation oncologist's view.Franz Zehentmayr, Andreas Rimner, Denise Bernhardt, Lukas Käsmann, Eleni Gkika
Clinical and Translational Radiation Oncology. 2026-11-01 - External validation of dose to heart substructures and the association with non-cancer death after SBRT in stage I-II NSCLC patients.Barbara Stam, Robin Wijsman, Maria Thor, Andreas Rimner, Joseph O Deasy
Radiotherapy and Oncology. 2026-10-01 - Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial.Narek Shaverdian, Michael Offin, Nicolas Toumbacaris, Jasme Lee, Karmelina Charalambous
Nature Communications. 2026-09-07
Journal Articles
- Design and Validation of a MV/kV Imaging Based Markerless Tracking System for Assessing Real Time Lung Tumor MotionAndreas Rimner, MD, Medical Physics
- Stereotactic Body Radiation Therapy (SBRT) Improves Local Control and Overall Survival Compared to Conventionally Fractionated Radiation for Stage I Non-Small Cell Lun...Kenneth E Rosenzweig, Fauzia Shaikh, Daphna Y Gelblum, Shaun U Din, Andreas Rimner, Abraham J Wu, Acta Oncologica
Authored Content
- The Expanding Role of Radiation Therapy for Thymic MalignanciesNovember 2017
Press Mentions
Local Therapy Extends Use of Targeted Drugs in Oligoprogressive Lung CancerOctober 20th, 2022
Treatment Planning and Outcomes Effects of Reducing the Preferred Mean Esophagus Dose for Conventionally Fractionated Non‐Small Cell Lung Cancer RadiotherapyJanuary 25th, 2021
The Expanding Role of Radiation Therapy for Thymic MalignanciesSeptember 3rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
